Drug stocks slip; OSI slides on FDA move
December 17, 2009 at 10:16 AM EST
OSI Pharmaceuticals led the downward trend for the larger-cap biotech issues after a setback for its lung-cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.